Where does Biomeme Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biomeme Inc. ranks #23,982 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biomeme Inc. hold?

Biomeme Inc. holds 11 US utility patents granted between 2017 and 2025, spanning 5 technology areas.

What is Biomeme Inc.'s Innovation Score?

Biomeme Inc. has an Innovation Score of 48.8 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biomeme Inc. focus on?

Biomeme Inc.'s top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 11 patents, ranking #169 of 1,325 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Biomeme Inc.'s patent grant rate increasing or decreasing?

Biomeme Inc.'s recent grant velocity is +133% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Biomeme Inc.'s patents?

Biomeme Inc.'s patents average 20.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biomeme Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Biomeme Inc.

USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biomeme ranks #23,982 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 5 technology areas.

#23,982
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.8/100): 20.6
avg claims per patent: +133%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23982 · US Corporation #23,982 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #23,982/49,997
PHOTO-FINISH Beko
CPC-NARROW B01L · 5 areas
INNOV-PAR 48.8/100
CLAIMS-DENSE 20.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +133% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Beko Technologies GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biomeme’s 48.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (18%) Velocity 20.0 pts (41%) Breadth 7.9 pts (16%) Claim depth 12.3 pts (25%)

Qualcomm Incorporated · highest

85
Biomeme · this assignee

49
3D Lighting… · lowest

7

What this shows Biomeme's Innovation Score is 48.8/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biomeme?

Each dot is one of Biomeme’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biomeme’s own 20.6 claims/patent is ABOVE the 12.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biomeme vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biomeme's grants concentrate

Biomeme Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2017. By volume, Biomeme sits between Beko Technologies GMBH and Biothera Inc..

Biomeme's three-year grant acceleration

Biomeme Inc. shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Beko

11
BGT Materials

11
BIO ON S P A

11
Biomea Fusion

11
Biopath Automation

11
Bioprojet

11
Biosafe

11
Biothera

11
Biomeme ◀

11

What this shows Biomeme holds 11 patents at rank #23,962, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biomeme

By rank, the assignees closest to #23,962 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Biomeme's primary technology class.

Biomeme's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Biomeme Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	9.1%
2018	1	9.1%
2019	1	9.1%
2020	1	9.1%
2022	1	9.1%
2023	2	18.2%
2024	3	27.3%
2025partial year	1	9.1%

Which technologies does Biomeme Inc. patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 11

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 8

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biomeme Inc.'s patent record in context - here's where to go next.

Biomeme Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 100% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #23,982 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biomeme Inc. against Beko Technologies GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.